TNGX
Tango Therapeutics Inc
23.20$
-4.9%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | – | 100.0% | |
| 5.7% | 11.4% | 9.7% | 3.2% | – | 15.1% | – | 19.6% | 1.0% | – | – | – | – | |
| 94.3% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 80.4% | 100.0% | – | – | – | – | |
| 253.0% | 577.0% | 588.2% | 194.5% | 286.6% | 824.3% | 675.9% | 1,011.7% | 57.3% | – | – | – | 249.7% | |
| 85.8% | 167.6% | 164.8% | 54.2% | 96.7% | 269.4% | 212.9% | 356.5% | 16.6% | – | – | – | 105.0% | |
| 333.1% | 744.7% | 753.0% | 248.7% | 383.3% | 1,093.7% | 888.8% | 1,368.2% | 73.8% | – | – | – | 351.6% | |
| -238.8% | -644.7% | -653.0% | -148.7% | -283.3% | -993.7% | -788.8% | -1,287.9% | 26.2% | – | – | – | -253.4% | |
| – | 10.7% | – | – | – | – | – | – | – | – | – | – | – | |
| -207.2% | -565.6% | -585.3% | -128.2% | -250.8% | -913.8% | -738.9% | -1,220.3% | 29.5% | – | – | – | -230.0% | |
| 0.2% | 0.9% | 0.6% | 0.3% | 0.5% | 1.2% | 0.6% | 1.1% | 0.0% | – | – | – | -0.1% | |
| -207.4% | -566.4% | -585.9% | -128.6% | -251.3% | -915.0% | -739.5% | -1,221.4% | 29.5% | – | – | – | -229.9% | |
| -201.5% | -554.2% | -575.6% | -125.1% | -245.5% | -898.7% | -727.4% | -1,200.7% | 30.5% | – | – | – | -227.3% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.